SLICC Criteria for Systemic Lupus Erythematosus (SLE) 2012

SLICC SLE Criteria 2012
Clinical Criteria (need ≥1)
Acute Cutaneous Lupus
Chronic Cutaneous Lupus
Oral/Nasal Ulcers
Non-Scarring Alopecia
Synovitis (≥2 joints)
Serositis
Renal (proteinuria or red cell casts)
Neurologic (seizures, psychosis, etc.)
Hemolytic Anemia
Leukopenia (<4000) or Lymphopenia (<1000)
Thrombocytopenia (<100,000)
Immunologic Criteria (need ≥1)
ANA
Anti-dsDNA
Anti-Sm
Antiphospholipid Antibody
Low Complement (C3, C4, or CH50)
Direct Coombs Test
Alternate Pathway
Biopsy-Proven Lupus Nephritis
SLICC Criteria: Not Met
Criteria Not Met
Patient does not meet SLICC 2012 criteria. Need ≥4 criteria (with ≥1 clinical AND ≥1 immunologic) OR biopsy-proven lupus nephritis with ANA or anti-dsDNA.
Provides criteria for diagnosis of SLE.

Why Use

May provide benefit for clinicians by documenting key disease features, aiding in the diagnosis of SLE.

When to Use

Utilize when systemic lupus erythematosus (SLE) is clinically suspected based on patient presentation. Use for classifying patients in clinical studies to ensure consistent criteria.

Formula

SLE diagnosis is positive if patient has: Biopsy-proven nephritis compatible with SLE and ANA or anti-dsDNA antibodies Or: ≥4 of the criteria below at any time including at least one clinical criterion and one immunological criterion. Clinical criteria (≥1 must be present): Criteria Acute cutaneous lupus Lupus malar rash (not malar discoid) Bullous lupus Toxic epidermal necrolysis variant of SLE Maculopapular lupus rash Photosensitive lupus rash (not dermatomyositis) Subacute cutaneous lupus (nonindurated psoriasiform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias) Chronic cutaneous lupus Localized (above the neck) and/or generalized (above and below the neck) classical discoid rash Hypertrophic (verrucous) lupus Lupus panniculitis (profundus) Mucosal lupus Lupus erythematosus tumidus Chilblains lupus Discoid lupus/lichen planus overlap Oral ulcers (in absence of other causes) Palate Buccal Tongue Nasal ulcers Nonscarring alopecia (in absence of other causes) Synovitis involving ≥2 joints, characterized by swelling or effusion OR tenderness in ≥2 joints and 30 mins or more of morning stiffness Serositis Typical pleurisy for >1 day, pleural effusions, or pleural rub Typical pericardial pain for >1 day, pericardial effusion, pericardial rub, or pericarditis by EKG (in absence of other causes) Renal Urine protein/creatinine (or 24 hr urine protein) representing 500 mg of protein/24 hr RBC casts Neurologic Seizures Psychosis Mononeuritis multiplex (in absence of other causes) Myelitis Peripheral or cranial neuropathy (in absence of other causes) Acute confusional state (in absence of other causes) Hemolytic anemia (in absence of other causes) Leukopenia (<4,000/mm³ at least once) or lymphopenia (<1,000/mm³ at least once) in absence of other causes Thrombocytopenia (<100,000/mm³ at least once) in absence of other causes Immunological criteria (≥1 must be present): Criteria ANA above laboratory reference range Anti-dsDNA above laboratory reference range, except ELISA (2x above laboratory reference range) Anti-Sm Antiphospholipid antibody Lupus anticoagulant False positive RPR Medium or high titer anticardiolipin (IgA, IgG or IgM) Anti-β 2 glycoprotein (IgA, IgG or IgM) Low complement Low C3 Low C4 Low CH50 Positive direct Coombs test (in the absence of hemolytic anemia)

Pearls / Pitfalls

Developed by the Systemic Lupus Collaborating Clinics (SLICC) to address weaknesses in the 1997 American College of Rheumatology (ACR) classification, reflecting the understanding and diagnostic approaches for SLE as of 2012. Primarily designed for classification in research and may not capture all clinical diagnostic nuances.

Advice

Corroborate criteria results with clinical judgment, specialist consultation, and additional diagnostic tests as necessary. Initiate appropriate treatment strategies based on a confirmed diagnosis, tailored to the patient's specific manifestations. Engage rheumatologists or other relevant specialists for comprehensive management of multisystem involvement.

Similar Posts